Omnipaque 350 mg I/ml Solution for Injection, PA 0735/006/020 and Visipaque 320 mg l/ml Solution for Injection, PA 0735/009/013, Batch Recall
23/03/2026
Medicines for human use
Recall
We wish to advise you that the below listed batches of Omnipaque 350 mg I/ml Solution for Injection and
Visipaque 320 mg l/ml Solution for Injection are being recalled with immediate effect.
This recall action is to user level.
The recall is due to the potential presence of particles in 100ml polypropylene bottles in certain batches of
the products. Glass bottle presentations are not affected by this defect.
The recall letter, dated 20th March 2026, can be downloaded in the Documents section at the bottom of this webpage.
Product information
- Product name
-
Omnipaque 350 mg I/ml Solution for Injection
Visipaque 320 mg l/ml Solution for Injection - Authorisation holder
- GE Healthcare AS
- Authorisation number
-
PA 0735/006/020, PA 0735/009/013
- Serial or batch number and expiry date
-
Omnipaque 350 mg I/ml Solution for Injection, PA 0735/006/020,
Batch number: 17413362 Expiry Date: 15.10.2028
Visipaque 320 mg l/ml Solution for Injection, PA 0735/009/013,
Batch number: 17230467 Expiry Date: 14.08.2028
- Human or veterinary medicine
- Human Medicine
- Target audience
- Pharmacists
- Recall level
- User level
Actions to be taken
Information for Pharmacists
Pharmacists are requested to perform the following actions:
- Immediately identify and quarantine any packs from the above-listed batches within your facility. This includes stock at all locations within your pharmacy or facility, including at ward level or clinics.
- Please complete and return the form attached to the Recall letter (in the Documents section at the bottom of this page) by emailing it to Recall.89013@gehealthcare.com. GE Healthcare will arrange for product return.
- Please make all relevant health care professionals aware of the contents of the recall letter (in the Documents section at the bottom of this page).
- If you have supplied units from the above listed batches to any other hospital, healthcare facility or user, please notify them of this recall action and forward them a copy of the recall letter (in the Documents section at the bottom of this page).
Information for Patients and Public
No action is required by patients and public. If you have any queries, please contact your pharmacist or healthcare provider.